| http://www.w3.org/ns/prov#value | - In addition, we are investigating ways to therapeutically modulate phenotypic transitions of SMC-P as a means to treat a wide range of major human diseases including atherosclerosis, hypertension, aortic aneurysms, peripheral vascular disease, cancer, and microvascular complications of diabetes/obesity that in aggregate account for >75% of all deaths worldwide.
|
